Koronis Pharmaceuticals


Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998. Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration. The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus infection. The company also has products in development for the treatment of hepatitis C and RSV infection.